nektar therapeutics (NKTR:NASDAQ GS)
Stephen K. Doberstein Ph.D.
Chief Scientific Officer and Senior Vice President, Nektar Therapeutics
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 5 different industries.|
As of Fiscal Year 2014
Dr. Stephen K. Doberstein, also known as Steve, Ph.D. has been Chief Scientific Officer and Senior Vice President of Nektar Therapeutics since January 6, 2010. Dr. Doberstein served as Vice President of Research of XOMA Ltd. since October 28, 2008. He has 17 years of experience in biotechnology research and development. Most recently, he served as Vice President of Research at Five Prime Therapeutics, Inc., since July 2004. Prior to his position at Five Prime, he served ...
455 Mission Bay Boulevard SouthPhone: 415-482-5300
San Francisco, California 94158
Board Members Memberships*There is no Board Members Memberships data available.
Johns Hopkins School of Medicine
University of Delaware
|Michael W. Aguiar||Chief Executive Officer, President and Director|
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|Peter S. Greenleaf||Chief Executive Officer and Director|
Sucampo Pharmaceuticals, Inc.
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee|
Emergent BioSolutions, Inc.
|$1.2M||Compensation as of Fiscal Year 2014.|